<DOC>
	<DOC>NCT02695303</DOC>
	<brief_summary>To evaluate the Sun Protection Factor (SPF) efficacy on human skin.</brief_summary>
	<brief_title>18790 - Sun Protection Factor Assay</brief_title>
	<detailed_description />
	<criteria>Fitzpatrick Skin Type l, ll and/or lll for UVB testing. Fitzpatrick Skin Type ll, lll and/or lV for UVA testing. Male and female Aged between 1870 years old. Good health as determined from the HRL SHF Signed and dated Informed Consent Form Signed and dated HIPAA (Health Insurnace Portability and Accountability Act) Form An unbmbiguous MED (Minimal Erythema Dose) or MPPD (Minimal Persistent Pigment Darkening Dose) Subjects on test at any other research laboratory or clinic. Known allergy or sensitivity to sunscreens, cosmetics and toiletries, topical drugs and/or ultraviolet light. Preexisting dermatologic conditions which have been dianoses by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study. Preexisting other medical conditions (e.g. adult asthma. diabetes). Treatment with antihistamines or corticosteroids within one week prior to initiation of the test. Treatment with antibiotics within two weeks prior to initiation of the test. Chronic medication which could affect the results of the study. Known pregnant or nursing women.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>